BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
2.710
0.00 (0.00%)
At close: Jun 27, 2025, 4:00 PM
2.740
+0.030 (1.11%)
After-hours: Jun 27, 2025, 6:39 PM EDT
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $4.87 million as of June 27, 2025. Its market cap has decreased by -45.97% in one year.
Market Cap
4.87M
Enterprise Value
1.60M
1-Year Change
-45.97%
Ranking
Category
Stock Price
$2.71
Market Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $4.87M, a decrease of -88.44%. That is a compound annual growth rate of -36.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 4.98M | -0.97% |
| Dec 31, 2024 | 5.03M | -46.33% |
| Dec 29, 2023 | 9.36M | -94.33% |
| Dec 30, 2022 | 165.03M | -54.75% |
| Dec 31, 2021 | 364.69M | 54.35% |
| Dec 31, 2020 | 236.28M | 460.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Linde | 217.59B |
| BHP Group | 118.98B |
| Rio Tinto Group | 95.54B |
| The Sherwin-Williams Company | 86.06B |
| Southern Copper | 77.91B |
| Ecolab | 75.61B |
| Newmont | 64.36B |
| Air Products and Chemicals | 62.74B |